the results suggest that optimal clinical beta blockade with betaxolol , in doses sufficient to significantly reduce the frequency of angina and improve exercise capacity in patients with stable angina pectoris and mild to moderate lv systolic dysfunction , does not cause significant deterioration of lv systolic function or produce lv failure .
C0002962
angina
C0340288
stable angina pectoris